Tag: Viral Vector Production (Research-Use) Market Share

Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.

Viral Vector Production (Research-Use) Market Size Outlook: How Quickly Will Revenue Expand Through 2030?

The viral vector production (research-use) market has seen rapid expansion in recent years. This market is anticipated to increase from $1.77 billion in 2025 to $2.04 billion in 2026, showing a compound annual growth rate (CAGR) of 15.2%. The historical growth of this market can be linked to heightened investment in gene therapy research, the enlargement of academic and translational research programs, the emergence of advanced cell culture technologies, the growing application of viral vectors in oncology studies, and the rise in contract research activities.

The viral vector production (research-use) market is projected for rapid expansion in the coming years, reaching $3.56 billion by 2030, driven by a compound annual growth rate (CAGR) of 14.9%. This growth over the forecast period stems from factors such as increasing demand for advanced gene delivery tools, greater integration of automation in research settings, the broadening scope of CRISPR and gene editing investigations, enhanced partnerships between academic institutions and biopharmaceutical companies, and a heightened emphasis on reproducibility and standardization. Key trends identified for this period encompass the wider implementation of scalable viral vector manufacturing platforms, a growing need for high-purity research-grade vectors, increased utilization of suspension cell culture systems, the advancement of automated upstream and downstream processing, and a stronger focus on vector characterization and quality control.

Get A Free Sample Report With In-Depth Market Insights:

https://thebusinessresearchcompany.com/sample_request?id=52843707&type=smp&name=Viral%20Vector%20Production%20%28Research-Use%29%20Market%20Report%202026&utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Viral Vector Production (Research-Use) Market Growth Factors Behind Sustained Expansion

The increasing incidence of genetic disorders is anticipated to propel the expansion of the viral vector production (research-use) market in the coming years. Genetic disorders are conditions or illnesses stemming from abnormalities in an individual’s deoxyribonucleic acid, which can be inherited from one or both parents or manifest due to new genetic mutations. The rise in these disorders is attributable to increasing parental age, which elevates the likelihood of genetic mutations being passed down to offspring. The expanding prevalence of genetic disorders underpins the growth of viral vector production (research-use) by fueling the demand for sophisticated gene delivery tools necessary for investigating disease mechanisms and devising potential therapeutic strategies. For instance, in November 2024, data from the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, reported that Trisomy 21 (Down syndrome) affects approximately 1 in 643 births, resulting in about 5,713 new cases annually, and Trisomy 18 occurs in roughly 1 in 3,336 births, totaling around 1,101 cases yearly. Consequently, the rising occurrence of genetic disorders is expected to drive the growth of the viral vector production (research-use) market.

Viral Vector Production (Research-Use) Market Segment Outlook: Which Categories Are Growing Fastest?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Viral Vector Production (Research-Use) Market Industry Trends Fueling Future Revenue Growth

Major companies in the viral vector production market are prioritizing the development of advanced solutions, including specialized cell culture media, to enhance transfection efficiency, increase viral vector yields, and ensure consistent quality for research applications. Cell culture media are nutrient-dense solutions crafted to support cell growth and maintenance outside their natural habitat. They comprise vital components such as amino acids, vitamins, and growth factors, optimized for particular cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, unveiled BalanCD HEK293 Viral Feed, the world’s inaugural chemically defined nutrient feed specifically optimized for HEK293 suspension cultures employed in AAV viral vector manufacturing. Through this offering, the company seeks to significantly boost adeno-associated virus (AAV) yields, showing up to 67% improvement in viral packaging efficiency compared to basal media. The feed is engineered for scalable gene therapy and biotech workflows, delivering consistent performance across formats and compatibility with multiple media systems.

Viral Vector Production (Research-Use) Market Leading Companies And Competitive Benchmarking

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

View The Full Viral Vector Production (Research-Use) Market Report:

https://thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report?utm_source=Blogs&utm_medium=Paid&utm_campaign=Oct_PR

Viral Vector Production (Research-Use) Market Regional Analysis And Top Geography

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Reach Out To Our Team:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Viral Vector Production (Research-Use) Market Growth From $2.04 Billion In 2026 To $3.56 Billion By 2030 At A CAGR Of 14.9%

The market for viral vector production intended for research applications has experienced notable expansion in recent times. Projected to rise from $1.77 billion in 2025 to $2.04 billion in 2026, this reflects a compound annual growth rate (CAGR) of 15.2%. This historical growth has been driven by heightened funding for gene therapy research, the broadening of academic and translational research initiatives, the accessibility of sophisticated cell culture methods, an increased application of viral vectors in oncology investigations, and a surge in contract research operations.

The market size for viral vector production (research-use) is anticipated to expand rapidly over the coming years. By 2030, it is projected to reach $3.56 billion, driven by a compound annual growth rate (CAGR) of 14.9%. This growth in the forecast period is largely fueled by a rising need for advanced gene delivery tools, greater adoption of automation within research labs, expanded research into CRISPR and gene editing, increased partnerships between academic institutions and biopharmaceutical companies, and a heightened emphasis on reproducibility and standardization. Key trends shaping the forecast period include a growing preference for scalable manufacturing platforms for viral vectors, an increased demand for high-purity research-grade vectors, wider use of suspension cell culture systems, expansion of automated upstream and downstream processes, and a stronger focus on vector characterization and quality assurance.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp&utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Viral Vector Production (Research-Use) Market Industry Drivers: What Is Driving Revenue Growth?

The anticipated expansion of the viral vector production market for research purposes is being driven by the increasing prevalence of genetic disorders. These disorders arise from abnormalities in an individual’s deoxyribonucleic acid, which may be inherited from either parent or emerge from new genetic mutations. Their rising frequency is linked to advanced parental age, which heightens the risk of passing genetic mutations to children. This growing incidence fuels demand for sophisticated gene delivery tools essential for studying disease mechanisms and creating potential therapies, thereby supporting market growth. For example, in November 2024, the Centers for Disease Control and Prevention (CDC), a US governmental public health body, reported that Trisomy 21 (Down syndrome) affects roughly 1 in 643 births, leading to about 5,713 new cases each year, while Trisomy 18 occurs in around 1 in 3,336 births, or approximately 1,101 annual cases. Consequently, the rising frequency of genetic disorders is poised to advance the viral vector production (research-use) market.

Viral Vector Production (Research-Use) Market Segmentation And Category Breakdown

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Viral Vector Production (Research-Use) Market Growth Trends: What Is Influencing The Future Outlook?

Key players in the viral vector production industry are increasingly investing in the creation of innovative tools, particularly customized cell culture media, aimed at enhancing transfection efficiency, maximizing viral vector output, and maintaining reliable quality for research purposes. Cell culture media consist of nutrient-dense formulations that facilitate the cultivation and preservation of cells outside their native environment, incorporating critical components such as amino acids, vitamins, and growth factors tailored to specific cell varieties and uses. A notable example occurred in January 2023, when FUJIFILM Irvine Scientific, a life sciences company headquartered in the United States, unveiled BalanCD HEK293 Viral Feed, the first chemically defined nutrient supplement specifically engineered for HEK293 suspension cultures utilized in AAV viral vector production. With this product, the company intends to achieve substantial increases in adeno-associated virus (AAV) yields, demonstrating up to a 67% improvement in viral packaging efficiency compared to basal media. This feed is designed to support scalable gene therapy and biotechnological operations, delivering consistent performance across different formats and ensuring compatibility with a variety of media systems.

Viral Vector Production (Research-Use) Market Competitive Analysis Of Major Industry Participants

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Access The Complete Viral Vector Production (Research-Use) Market Report:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=Jul_PR

Viral Vector Production (Research-Use) Market Regional Distribution: Which Areas Drive Market Expansion?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/?utm_source=BlogsPR&utm_medium=Paid&utm_campaign=home_page_test

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.

What Is The Expected Market Value Outlook For The Viral Vector Production (Research-Use) Market Through 2030?

The viral vector production (research-use) market has shown rapid expansion in recent years. It is anticipated to grow from $1.77 billion in 2025 to $2.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.2%. This historical growth can be attributed to several factors, including increased investment in gene therapy research, the expansion of academic and translational research programs, the availability of advanced cell culture technologies, the rising use of viral vectors in oncology studies, and the growth of contract research activities.

The viral vector production (research-use) market is poised for significant expansion in the coming years, projected to reach a valuation of $3.56 billion by 2030, exhibiting a robust compound annual growth rate (CAGR) of 14.9%. This anticipated growth throughout the forecast period stems from several key factors, including the escalating demand for advanced gene delivery tools, increased integration of automation within research laboratories, the broadening scope of CRISPR and gene editing research, stronger partnerships between academic institutions and biopharmaceutical companies, and a heightened emphasis on reproducibility and standardization. Concurrently, dominant trends during this period are expected to feature a greater uptake of scalable viral vector manufacturing platforms, an escalating need for high-purity research-grade vectors, the expanded deployment of suspension cell culture systems, the advancement of automated upstream and downstream processing techniques, and a sharpened focus on both vector characterization and quality control.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

What Are The Main Drivers Accelerating The Growth Of The Viral Vector Production (Research-Use) Market?

The increasing incidence of genetic disorders is anticipated to drive the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are conditions or illnesses resulting from abnormalities in an individual’s deoxyribonucleic acid, which can be inherited from either parent or arise from new genetic mutations. This increase in genetic disorders is linked to rising parental age, which elevates the probability of genetic mutations being passed to offspring. The growing prevalence of genetic disorders supports the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools essential for studying disease mechanisms and developing potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) market.

How Does Segment Analysis Break Down The Viral Vector Production (Research-Use) Market Structure?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Trends Are Impacting The Viral Vector Production (Research-Use) Market?

Leading companies within the viral vector production market are prioritizing the development of advanced solutions, such as specialized cell culture media, to enhance transfection efficiency, boost viral vector yields, and ensure consistent quality for research applications. Cell culture media are nutrient-rich solutions formulated to support cell growth and maintenance outside their native environment, containing essential components like amino acids, vitamins, and growth factors optimized for specific cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, launched BalanCD HEK293 Viral Feed, recognized as the world’s first chemically defined nutrient feed specifically optimized for HEK293 suspension cultures used in AAV viral vector manufacturing. Through this launch, the company aims to significantly increase adeno-associated virus (AAV) yields, demonstrating up to 67% improvement in viral packaging efficiency compared to basal media. The feed is designed for scalable gene therapy and biotech workflows, providing consistent performance across formats and compatibility with multiple media systems.

Which Industry Players Are Present In The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Access The Complete Viral Vector Production (Research-Use) Market Report:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Is The Largest Regional Market In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Viral Vector Production (Research-Use) Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Will The Market Value Of The Viral Vector Production (Research-Use) Market Progress Between 2026 And 2030?

The viral vector production (research-use) market size has witnessed swift expansion in recent years. It is projected to increase from $1.77 billion in 2025 to $2.04 billion in 2026, reflecting a compound annual growth rate (CAGR) of 15.2%. This historical growth can be ascribed to heightened investment in gene therapy research, the broadening of academic and translational research programs, the presence of advanced cell culture technologies, the increasing application of viral vectors in oncology studies, and the expansion of contract research activities.

The viral vector production (research-use) market size is projected for significant expansion over the coming years, with an anticipated growth to $3.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. This projected growth can be attributed to several factors, including an increasing demand for next-generation gene delivery tools, the rising adoption of automation in research laboratories, the expansion of CRISPR and gene editing research, growing collaboration between academia and biopharma, and an increasing focus on reproducibility and standardization. Prominent trends within the forecast period encompass the increasing adoption of scalable viral vector manufacturing platforms, a rising demand for high-purity research-grade vectors, the growing use of suspension cell culture systems, the expansion of automated upstream and downstream processing, and an enhanced focus on vector characterization and quality control.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Which Drivers Are Supporting The Viral Vector Production (Research-Use) Market Growth?

The escalating occurrence of genetic disorders is projected to fuel the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are health conditions or diseases stemming from irregularities in an individual’s deoxyribonucleic acid, which can be inherited from one or both parents or arise from new genetic mutations. The increase in genetic disorders is attributable to rising parental age, which enhances the probability of genetic mutations being passed on to offspring. The increasing prevalence of genetic disorders underpins the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools necessary for studying disease mechanisms and developing potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the rising occurrence of genetic disorders is expected to propel the growth of the viral vector production (research-use) market.

What Are The Main Segments Within The Viral Vector Production (Research-Use) Market Segment Structure?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Trends Are Influencing The Evolution Of The Viral Vector Production (Research-Use) Market?

Leading companies in the viral vector production market are concentrating on developing advanced solutions, such as specialized cell culture media, to enhance transfection efficacy, increase viral vector output, and guarantee consistent quality for research uses. Cell culture media are nutrient-rich liquids crafted to support the proliferation and upkeep of cells outside their natural environment. They comprise essential elements like amino acids, vitamins, and growth factors, optimized for particular cell types and applications. For instance, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences firm, unveiled BalanCD HEK293 Viral Feed, which is the world’s initial chemically defined nutrient feed specifically tailored for HEK293 suspension cultures utilized in AAV viral vector manufacturing. Through this launch, the company aims to significantly elevate adeno-associated virus (AAV) yields, showing up to 67% improvement in viral packaging efficiency when compared to basal media. This feed is engineered for scalable gene therapy and biotech workflows, providing reliable performance across formats and compatibility with multiple media systems.

Who Are The Companies Participating In The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Get The Full Viral Vector Production (Research-Use) Market Report:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

Which Region Has The Greatest Market Share In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Viral Vector Production (Research-Use) Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Is The Market Size Of The Viral Vector Production (Research-Use) Market In 2026 And What Value Is Projected For 2030?

The market size for viral vector production (research-use) has seen rapid expansion in recent years. Projections indicate it will expand from $1.77 billion in 2025 to reach $2.04 billion by 2026, exhibiting a compound annual growth rate (CAGR) of 15.2%. Historically, this growth can be attributed to several factors, including increased investment in gene therapy research, the broadening of academic and translational research programs, the availability of cutting-edge cell culture technologies, the escalating application of viral vectors in oncology studies, and the expansion of contract research activities.

The market size for viral vector production (research-use) is anticipated to experience swift expansion over the next few years. It is projected to reach $3.56 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 14.9%. This growth during the forecast period is attributable to factors such as increasing demand for next-generation gene delivery tools, rising adoption of automation within research laboratories, the expansion of CRISPR and gene editing research, growing collaboration between academia and biopharma, and an increasing focus on reproducibility and standardization. Prominent trends expected in the forecast period include the increasing adoption of scalable viral vector manufacturing platforms, a rising demand for high-purity research-grade vectors, the growing use of suspension cell culture systems, an expansion of automated upstream and downstream processing, and an enhanced focus on vector characterization and quality control.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Viral Vector Production (Research-Use) Market?

The increased occurrence of genetic disorders is anticipated to stimulate the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are conditions or illnesses resulting from irregularities in an individual’s deoxyribonucleic acid, which can be inherited from one or both parents or emerge from new genetic mutations. The uptick in genetic disorders is linked to rising parental age, thereby increasing the probability of genetic mutations being passed to offspring. The expanding incidence of genetic disorders supports the development of viral vector production (research-use) by fueling the need for advanced gene delivery tools to investigate disease mechanisms and formulate potential therapeutic strategies. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Thus, the growing occurrence of genetic disorders is projected to drive the growth of the viral vector production (research-use) market.

What Are The Key Segments Of The Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

What Key Trends Are Influencing The Development Of The Viral Vector Production (Research-Use) Market?

Firms operating in the viral vector production market are concentrating on developing sophisticated solutions, such as specialized cell culture media, to enhance transfection efficiency, boost viral vector yields, and maintain uniform quality for research purposes. These cell culture media are nutrient-dense preparations intended to sustain cell growth and upkeep outside their natural habitat. They comprise vital elements such as amino acids, vitamins, and growth factors, tailored for particular cell types and uses. As an illustration, FUJIFILM Irvine Scientific, a US-based life sciences firm, launched BalanCD HEK293 Viral Feed in January 2023. This product represents the world’s initial chemically defined nutrient feed, specifically optimized for HEK293 suspension cultures employed in AAV viral vector manufacturing. With this introduction, the company intends to substantially increase adeno-associated virus (AAV) yields, showing up to 67% greater viral packaging efficiency than with basal media. This feed is engineered for scalable gene therapy and biotechnology workflows, providing uniform performance across various formats and compatibility with numerous media systems.

Who Are The Leading Companies Operating In The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Read the full viral vector production (research-use) market report here:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Are The Leading Geographic Regions In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Viral Vector Production (Research-Use) Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Uncover key drivers, emerging technologies, and competitive movements shaping the viral vector production (research-use) market from 2026–2035 with trusted insights from The Business Research Company

What long-term size projections exist for the Viral Vector Production (Research-Use) Market covering 2026–2035?

The viral vector production (research-use) market has experienced rapid growth in recent years. This market is anticipated to expand from $1.77 billion in 2025 to $2.04 billion in 2026, driven by a compound annual growth rate (CAGR) of 15.2%. Historically, this growth has been attributed to factors such as increased investment in gene therapy research, the expansion of academic and translational research programs, the availability of advanced cell culture technologies, a rising utilization of viral vectors in oncology studies, and the growth of contract research activities.

The viral vector production (research-use) market size is projected to undergo substantial expansion over the next few years. It is forecast to achieve a value of $3.56 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 14.9%. This projected growth throughout the forecast period stems from factors such as increasing demand for advanced gene delivery tools, the growing integration of automation in research laboratories, the broadened scope of CRISPR and gene editing research, an uptick in collaboration between academic institutions and biopharmaceutical firms, and a heightened emphasis on reproducibility and standardization. Prominent trends for the forecast period involve the increasing uptake of scalable viral vector manufacturing platforms, a rising need for high-purity research-grade vectors, the expanding utilization of suspension cell culture systems, the wider deployment of automated upstream and downstream processing, and a stronger focus on vector characterization and quality control.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

Which Drivers Are Impacting The Competitive Landscape Of The Viral Vector Production (Research-Use) Market?

The growing incidence of genetic disorders is expected to drive the expansion of the viral vector production (research-use) market moving forward. Genetic disorders are illnesses or states resulting from irregularities in an individual’s deoxyribonucleic acid, which can be passed down from one or both parents or arise from new genetic mutations. The increase in genetic disorders is attributed to rising parental age, enhancing the likelihood of genetic mutations being transferred to offspring. The increasing commonness of genetic disorders supports the growth of viral vector production (research-use) by stimulating demand for advanced gene delivery tools to examine disease mechanisms and develop potential therapeutic approaches. For instance, in November 2024, according to the Centers for Disease Control and Prevention (CDC), a US-based government public health agency, Trisomy 21 (Down syndrome) occurs in about 1 in 643 births, resulting in approximately 5,713 new cases annually, and Trisomy 18 occurs in about 1 in 3,336 births, or roughly 1,101 cases yearly. Therefore, the increasing occurrence of genetic disorders is anticipated to propel the growth of the viral vector production (research-use) market.

What Segments Are Identified Within The Structure Of The Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market covered in this report is segmented –

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Which Innovation Trends Are Advancing Developments Within The Viral Vector Production (Research-Use) Market?

Leading companies in the viral vector production market are concentrating on creating sophisticated solutions, including specialized cell culture media, to enhance transfection efficiency, increase viral vector yields, and guarantee consistent quality for research uses. Cell culture media are nourishing solutions formulated to sustain cell growth and maintenance outside their natural habitat. These solutions contain vital elements like amino acids, vitamins, and growth factors, optimized for particular cell types and applications. For example, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, unveiled BalanCD HEK293 Viral Feed, recognized as the world’s first chemically defined nutrient feed specifically optimized for HEK293 suspension cultures employed in AAV viral vector manufacturing. Through this introduction, the company seeks to substantially elevate adeno-associated virus (AAV) yields, demonstrating an improvement of up to 67% in viral packaging efficiency compared to basal media. This feed is engineered for scalable gene therapy and biotech workflows, ensuring reliable performance across different formats and compatibility with various media systems.

Which Key Market Players Are Investing In Expansion And Innovation Within The Viral Vector Production (Research-Use) Market?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, Mustang Bio Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

Which Regions Are Poised For Strategic Growth In The Viral Vector Production (Research-Use) Market?

North America was the largest region in the virtual vector production (research-use) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the viral vector production (research-use) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Viral Vector Production (Research-Use) Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2026, By The Business Research Company

Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Market Report 2026

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20

How Much Larger Is The Viral Vector Production (Research-Use) Market Expected To Become By 2029 Compared With Its 2025 Level?

The market size for viral vector production (research-use) has seen swift expansion in recent years. It is expected to rise from $1.54 billion in 2024 to $1.77 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 15.4%. The expansion observed in the past can be attributed to the development of basic genetic and cell biology research, an increase in infectious disease research, the widespread application of viral vectors in CRISPR and RNAi studies, the growing demand from cancer immunotherapy studies, and increasing academic interest alongside initial clinical trials in gene therapy.

The market for viral vector production (research-use) is anticipated to experience swift expansion in the coming years. Its valuation is projected to reach $3.10 billion by 2029, growing at a compound annual growth rate (CAGR) of 15.0%. This expansion during the projection period can be attributed to factors such as the increasing prevalence of genetic disorders, the expanding preclinical gene therapy pipeline, wider application in regenerative medicine investigations, intensified research into neurodegenerative diseases, and augmented funding for rare disease research. Key trends anticipated during this period encompass progress in gene therapy research, the implementation of automation in vector quality control (QC), the development of hybrid and chimeric vectors, automated upstream and downstream processes, and vector modification utilizing synthetic biology.

Unlock Your Free Sample Report for Exclusive Market Data:

https://www.thebusinessresearchcompany.com/sample.aspx?id=28350&type=smp

What Are The Key Drivers Of Growth In The Viral Vector Production (Research-Use) Market?

The increasing incidence of genetic conditions is anticipated to drive the expansion of the viral vector production (research-use) market in the foreseeable future. These disorders are defined as illnesses or states arising from irregularities in a person’s deoxyribonucleic acid, potentially passed down from one or both parents, or resulting from spontaneous genetic mutations. The surge in genetic disorders is linked to the growing age of parents, which heightens the probability of genetic mutations being transmitted to their children. The expanding commonness of genetic disorders supports the growth of viral vector production (research-use) by stimulating the need for sophisticated gene delivery instruments for investigating disease mechanisms and formulating prospective therapeutic strategies. As an illustration, in November 2024, data from the Centers for Disease Control and Prevention (CDC), a U.S. government public health organization, indicated that Trisomy 21 (Down syndrome) affects approximately 1 in 643 births, leading to around 5,713 new instances each year, while Trisomy 18 is observed in roughly 1 in 3,336 births, equating to about 1,101 cases annually. Consequently, the escalating frequency of genetic disorders is expected to fuel the expansion of the viral vector production (research-use) market.

Which Key Segments Fueling The Viral Vector Production (Research-Use) Market?

The viral vector production (research-use) market covered in this report is segmented as

1) By Type: Adeno-Associated Virus (AAV), Lentivirus, Adenovirus, Retrovirus, Other Types

2) By Production: Transient Transfection, Stable Cell Line, Viral Packaging System, Other Production Methods

3) By Workflow: Upstream Processing, Downstream Processing

4) By Application: Gene Therapy, Vaccines, Oncology, Infectious Diseases, Other Applications

5) By End-Use: Pharmaceutical And Biopharmaceutical Companies, Research Institutes

Subsegments:

1) By Adeno-Associated Virus: Single-Stranded Adeno-Associated Virus, Self-Complementary Adeno-Associated Virus, Hybrid Adeno-Associated Virus

2) By Lentivirus: Human Immunodeficiency Virus-Based Lentivirus, Feline Immunodeficiency Virus-Based Lentivirus, Equine Infectious Anemia Virus-Based Lentivirus

3) By Adenovirus: Replication-Competent Adenovirus, Replication-Deficient Adenovirus, Helper-Dependent Adenovirus

4) By Retrovirus: Gamma Retrovirus, Spumavirus (Foamy Virus), Alpha Retrovirus

5) By Other Types: Herpes Simplex Virus Vectors, Baculovirus Vectors, Sendai Virus Vectors

Which Key Trends Are Expected To Influence The Viral Vector Production (Research-Use) Market In The Coming Years?

Leading firms in the viral vector production market are concentrating on creating cutting-edge solutions, like tailored cell culture media, to enhance transfection efficiency, elevate viral vector output, and guarantee reliable quality for research purposes. These media are nutrient-dense liquids formulated to sustain cell growth and upkeep when cells are cultured outside their native conditions. They incorporate vital elements such as amino acids, vitamins, and growth factors, precisely optimized for particular cell types and their uses. As an example, in January 2023, FUJIFILM Irvine Scientific, a US-based life sciences company, launched BalanCD HEK293 Viral Feed, which is recognized as the world’s inaugural chemically defined nutrient feed, specifically tailored for HEK293 suspension cultures employed in AAV viral vector manufacturing. With this introduction, the company intends to substantially increase adeno-associated virus (AAV) yields, demonstrating an improvement of up to 67% in viral packaging efficiency when contrasted with basal media. This feed is engineered for scalable gene therapy and biotechnology processes, providing reliable performance across various formats and ensuring compatibility with diverse media systems.

Which Global Market Leaders Are Shaping The Future Of The Viral Vector Production (Research-Use) Sector?

Major companies operating in the viral vector production (research-use) market are Sanofi S.A., Thermo Fisher Scientific Inc., Merck KGaA, Becton, Dickinson and Company, Lonza Group AG, Sartorius AG, Charles River Laboratories International Inc., FUJIFILM Diosynth Biotechnologies U.S.A. Inc., Curia Inc., AGC Biologics GmbH, SK pharmteco Inc., Oxford Biomedica Plc, Waisman Biomanufacturing, Voyager Therapeutics Inc., FinVector Oy, Batavia Biosciences BV., GENEZEN LABORATORIES, BioNTech IMFS GmbH, VGXI Inc., Tonix Pharmaceuticals, Cell and Gene Therapy Catapult, and Mustang Bio Inc.

Download The Full Report For Exclusive Market Findings:

https://www.thebusinessresearchcompany.com/report/viral-vector-production-research-use-global-market-report

What Regional Growth Trends Are Shaping The Viral Vector Production (Research-Use) Market Outlook?

North America was the largest region in the virtual vector production (research-use) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in viral vector production (research-use) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Request A Customized Version Of The Viral Vector Production (Research-Use) Market Report:

https://www.thebusinessresearchcompany.com/customise?id=28350&type=smp

Browse Through More Reports Similar to the Global Viral Vector Production (Research-Use) Market 2025, By The Business Research Company

Viral Vector Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-vector-manufacturing-global-market-report

Viral And Non Viral Vector Manufacturing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/viral-and-non-viral-vector-manufacturing-global-market-report

Oral Expectorant Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/oral-expectorant-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model